HomeCompareBSX vs RSG

BSX vs RSG: Dividend Comparison 2026

BSX yields 3.18% · RSG yields 1.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RSG wins by $21.8K in total portfolio value· pulled ahead in Year 2
10 years
BSX
BSX
● Live price
3.18%
Share price
$62.93
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$0.32
Full BSX calculator →
RSG
RSG
● Live price
1.09%
Share price
$221.68
Annual div
$2.41
5Y div CAGR
44.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.0K
Annual income
$7,603.02
Full RSG calculator →

Portfolio growth — BSX vs RSG

📍 RSG pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSXRSG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSX + RSG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSX pays
RSG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSX
Annual income on $10K today (after 15% tax)
$270.14/yr
After 10yr DRIP, annual income (after tax)
$0.27/yr
RSG
Annual income on $10K today (after 15% tax)
$92.41/yr
After 10yr DRIP, annual income (after tax)
$6,462.57/yr
At 15% tax rate, RSG beats the other by $6,462.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSX + RSG for your $10,000?

BSX: 50%RSG: 50%
100% RSG50/50100% BSX
Portfolio after 10yr
$31.1K
Annual income
$3,801.67/yr
Blended yield
12.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BSX right now

BSX
Analyst Ratings
2
Strong
38
Buy
3
Hold
Consensus: Buy
Price Target
$108.35
+72.2% upside vs current
Range: $94.00 — $130.00
Altman Z
3.9
Piotroski
7/9
RSG
Analyst Ratings
20
Buy
15
Hold
Consensus: Buy
Price Target
$239.82
+8.2% upside vs current
Range: $220.00 — $255.00
Altman Z
3.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSX buys
6
RSG buys
6
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$BSX▲ Buy$1,001 - $15,0002026-02-10
Gilbert Cisneros🏢 House$BSX▲ Buy$1,001 - $15,0002026-01-30
Markwayne Mullin🏛 Senate$BSX▲ Buy$15,001 - $50,0002025-12-29
Markwayne Mullin🏛 Senate$BSX▲ Buy$15,001 - $50,0002025-12-29
Gilbert Cisneros🏢 House$BSX▼ Sell$1,001 - $15,0002025-12-24
Julie Johnson🏢 House$RSG▼ Sell$1,001 - $15,0002025-12-18
John Boozman🏛 Senate$BSX▼ Sell$1,001 - $15,0002025-12-17
John Boozman🏛 Senate$BSX▼ Sell$1,001 - $15,0002025-12-17
Gilbert Cisneros🏢 House$BSX▲ Buy$1,001 - $15,0002025-11-18
Julie Johnson🏢 House$RSG▼ Sell$1,001 - $15,0002025-11-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSXRSG
Forward yield3.18%1.09%
Annual dividend / share$2.00$2.41
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%44.6%
Portfolio after 10y$20.2K$42.0K
Annual income after 10y$0.32$7,603.02
Total dividends collected$321.00$19.8K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$108.35$239.82

Year-by-year: BSX vs RSG ($10,000, DRIP)

YearBSX PortfolioBSX Income/yrRSG PortfolioRSG Income/yrGap
1$10,859$158.91$10,857$157.20+$2.00BSX
2← crossover$11,700$80.63$11,848$230.65$148.00RSG
3$12,559$40.60$13,017$340.15$458.00RSG
4$13,459$20.36$14,434$505.05$975.00RSG
5$14,411$10.20$16,201$756.78$1.8KRSG
6$15,425$5.10$18,483$1,147.93$3.1KRSG
7$16,507$2.55$21,546$1,769.83$5.0KRSG
8$17,664$1.28$25,843$2,788.20$8.2KRSG
9$18,901$0.64$32,171$4,519.34$13.3KRSG
10$20,225$0.32$42,026$7,603.02$21.8KRSG

BSX vs RSG: Complete Analysis 2026

BSXHealthcare

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Full BSX Calculator →

RSGStock

Republic Services, Inc., together with its subsidiaries, offers environmental services in the United States. The company offers collection and processing of recyclable materials, collection, transfer and disposal of non-hazardous solid waste, and other environmental solutions. Its collection services include curbside collection of material for transport to transfer stations, landfills, or recycling processing centers; supply of recycling and waste containers; and renting of compactors. In addition, the company engages in the processing and sale of old corrugated containers, old newsprint, aluminum, glass, and other materials; and provision of landfill and transfer services. Further, it offers disposal of non-hazardous solid and liquid material and in-plant services, such as transportation and logistics. It serves small-container, large-container, and residential customers. As of December 31, 2021, the company operated through 356 collection operations, 239 transfer stations, 198 active landfills, 71 recycling processing centers, 6 saltwater disposal wells, and 7 deep injection wells, as well as 3 treatment, recovery, and disposal facilities in 41 states. It also operated 77 landfill gas-to-energy and renewable energy projects and had 124 closed landfills. The company was incorporated in 1996 and is based in Phoenix, Arizona.

Full RSG Calculator →
📬

Get this BSX vs RSG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSX vs SCHDBSX vs JEPIBSX vs OBSX vs KOBSX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.